6 results match your criteria: "the Affiliated First Hospital of Harbin Medical University[Affiliation]"
Environ Toxicol Pharmacol
August 2020
Department of Hematology, The Affiliated Hospital of Gulin Medical University, Guilin, China. Electronic address:
The aim of this study was to determine several key metabolites as potential biomarkers of daunorubicin (DNR) treatment of acute promyelocytic leukemia (APL) using APL blasts and NB4 cells. Samples which were obtained from 16 newly diagnosed APL patients and human APL NB4 cell lines were exposed to increasing concentrations of DNR (0 μM, 0.1 μM, 0.
View Article and Find Full Text PDFSci Rep
July 2015
Department of Immunology, Heilongjiang Provincial Key Laboratory for Infection and Immunity, Harbin Medical University, Harbin 150081, China.
Melanoma is one of the most aggressive skin cancers and is well known for its high metastatic rate. Studies have shown that epithelial mesenchymal transition (EMT) is essential for melanoma cell metastasis. However, the molecular mechanisms underlying EMT are still not fully understood.
View Article and Find Full Text PDFCell Biochem Biophys
July 2014
Department of Clinical Laboratory, The Affiliated First Hospital of Harbin Medical University, Harbin, 150001, China.
The elimination of viral covalently closed circular DNA (cccDNA) from the nucleus of infected hepatocytes is an obstacle to achieving sustained viral clearance during antiviral therapy of chronic hepatitis B virus (HBV) infection. The aim of our study was to determine whether treatment with siRNA is able to suppress viral cccDNA amplification using a HBV-transgenic mice model. The experimental results revealed that siRNAs can serve as efficient alternative anti-HBV agents, because they showed better inhibitory effect on viral replication and antigen expression in transgenic mice.
View Article and Find Full Text PDFCell Biochem Biophys
July 2014
Department of Clinical Laboratory, the Affiliated First Hospital of Harbin Medical University, Harbin, 150001, China.
Hepatitis B virus (HBV) infection is a major world-wide health problem. The major obstacles for current anti-HBV therapy are the low efficacy and the occurrence of drug resistant HBV mutations. Recent studies have demonstrated that combination therapy can enhance antiviral efficacy and overcome shortcomings of established drugs.
View Article and Find Full Text PDFLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
November 2009
Department of Otolaryngology-Head and Neck Surgery, the Affiliated First Hospital of Harbin Medical University, Harbin, 150001, China.
Objective: To study the prognosis factors of idiopathic sudden hearing loss.
Method: The clinical data of 165 patients with idiopathic sudden hearing loss were retrospectively studied and the computer software was used to investigate the relevant effects on prognosis.
Result: The prognosis of patients who had been treated within 14 days under the age of 55 were better.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
May 2009
Department of Otolaryngology-Head and Neck Surgery, the Affiliated First Hospital of Harbin Medical University, Harbin, 150001, China.
Objective: To explore the etiology and clinical features of non-invasive fungal rhinosinusitis and to evaluate the methods and curative effects of endoscopic sinus surgery.
Method: The denial and follow-up data of 59 patients with non-invasive fungal rhinosinusitis were retrospectively analyzed.
Result: Following up for 2-5 years, no complications were observed.